Related Experiment Video
Updated: May 28, 2026
Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens
Published on: July 29, 2011
Targeting glioma stem cells: enough to terminate gliomagenesis?
1Department of Neurosurgery, Second Affiliated Hospital of Suzhou University, Suzhou, Jiangsu 215004, China.
Objective:
To review the leading roles of glioma stem cells (GSCs) and their sophisticated interactions with other cells in the tissue remodeling process of gliomagenesis.
Data Sources:
Published articles about assessing GSCs in tumor initiation, progression, and multiple interactions with other cells in the special microenvironment were selected using PubMed. The search terms were "glioma stem cells", "tumorigenesis", and "microenvironment".
Study Selection:
Articles regarding the tissue remodeling of GSCs in gliomagenesis were selected.
Results:
GSCs exhibit enhanced tumor-initiating ability, could reestablish tumor, and were resistant to radiotherapy and chemotherapy. Studying the role of GSCs in gliomagenesis helps to develop targeting therapy against GSCs, which seems to be a cure for gliomas. However, sophisticated interactions between GSCs and their local microenvironment during tumor remodeling, including integrating with partially differentiated tumor cells, GSCs niche, neural stem cells (NSCs), normal glia, tumor-infiltrating lymphocytes, may obscure the leading role of GSCs during gliomagenesis, and make single targeting therapy unsuccessful.
Conclusions:
Understanding the biological behaviour of GSCs and their regulatory mechanisms may directly impact current efforts for more directed therapeutics against the highly aggressive gliomas. For multiple possible sources to turning into GSCs, simply eradicating the existing GSCs is not enough to be a cure for gliomas, blocking the potential sources of GSCs and ameliorating the local tumor inducing/promoting microenvironment should be a reasonable strategy.
Insights
Glioma stem cells (GSCs) drive gliomagenesis but interact intricately with their microenvironment. Targeting GSCs and their niche is crucial for effective glioma treatment.
Area of Science:
- Neuro-oncology
- Cancer Stem Cell Biology
- Tumor Microenvironment Research
Background:
- Glioma stem cells (GSCs) are key drivers of gliomagenesis, exhibiting potent tumor-initiation capabilities.
- GSCs possess inherent resistance to conventional therapies like radiotherapy and chemotherapy.
- The complex interplay between GSCs and their surrounding microenvironment significantly influences tumor progression.
Purpose of the Study:
- To review the pivotal roles of glioma stem cells (GSCs).
- To elucidate the sophisticated interactions of GSCs with other cells within the tumor microenvironment.
- To understand their contribution to the tissue remodeling process in gliomagenesis.
Main Methods:
- A comprehensive literature search was conducted on PubMed.
- Search terms included "glioma stem cells", "tumorigenesis", and "microenvironment".
- Articles focusing on GSC interactions and tissue remodeling in gliomagenesis were selected.
Main Results:
- GSCs demonstrate enhanced tumor-initiating potential and can regenerate tumors.
- Interactions with niche cells (e.g., neural stem cells, glia, lymphocytes) complicate GSC targeting.
- The complex tumor microenvironment can obscure the primary role of GSCs, limiting single-agent therapy efficacy.
Conclusions:
- Understanding GSC biology and regulatory mechanisms is vital for developing targeted glioma therapeutics.
- Effective glioma treatment requires targeting not only existing GSCs but also their sources and the tumor-promoting microenvironment.
- A multifaceted therapeutic strategy addressing GSC origins and their niche is essential for managing aggressive gliomas.
